Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 658 of 1,261
  1. US 9522241

    Controlled release nanoparticulate matter delivery system

    The Board of Regents of the University of Texas System · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  2. US 9522906

    Tetrahydroquinoline analogues as muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  3. US 9522289

    Selective fat removal using photothermal heating

    The Regents of the University of California · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  4. US 9522156

    Nitrated lipids and methods of making and using thereof

    University College Cardiff Consultants Limited · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  5. US 9522179

    Compositions and methods for modulating cardiac conditions

    The Regents of the University of Colorado · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  6. US 9522145

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  7. US 9522112

    System, method, and kit for selecting and preparing customized cosmetics

    MEDISCA PHARMACEUTIQUE INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  8. US 9522137

    Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  9. PT 2214636

    ORAL DOSAGE FORMS COMPRISING LICARBAZEPINE ACETATE

    BIAL-PORTELA & Cª S A [PT] · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  10. US 9522871

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  11. US 9523695

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  12. PT 2121138

    THERAPEUTICAL USES OF ESLICARBAZEPINE

    BIAL-PORTELA & Cª S A [PT] · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  13. US 9522955

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  14. US 9522185

    Human antibodies to GFR α3 and methods of treating pain associated with osteoarthritis or bone cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  15. US 9521845

    Beta-lactones as antibacterial agents

    Ludwig-Maximilians-Universitat Munchen · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted
  16. US 9517241

    Amelioration of intestinal fibrosis and treatment of Crohn's disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  17. US 9517228

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  18. US 9517240

    Methods and compositions for cancer prevention and treatment

    The Regents of the University of California · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  19. US 9517222

    Method for the treatment of senile dementia of the Alzheimer's type

    Phenomenome Discoveries Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  20. US 9517229

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  21. US 9517210

    Method for producing microcapsule powder

    Takeda Pharmaceutical Company Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  22. US 9518046

    Substituted aminopyrimidine compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  23. US 9517230

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  24. US 9517275

    Targeted therapy for the prevention of restenosis in the cardiovascular system

    Northwestern University · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.